Aging is associated with the decline of mitochondrial function, particularly in related metabolic diseases such as obesity, diabetes, and heart disease.
This invention provides a stem cell culture medium with small molecule inhibitors that can be used to maintain pluripotency in a laboratory atmospheric environment.
Prof. Jim Collman at Stanford and Dr. Paul Herrmann at Loma Linda Medical School have developed compositions and methods to inhibit platelet and platelet-driven clotting activity by a novel pathway.